(Q84496763)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725350%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Hepatitis: Treatment failure in chronic hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725350%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725350%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

4 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725350%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725350%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725350%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725350%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

366-367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725350%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrgastro.2011.104

6 February 2020

exact match

0 references

cites work

Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.104

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.104

Hepatitis B virus resistance to nucleos(t)ide analogues.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.104

No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.104

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.104

31 March 2020

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.104

Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.104

Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.104

HIV-1 viral load blips are of limited clinical significance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.104

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21725350

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRGASTRO.2011.104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725350%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference